The 2 most recent market catalysts affecting $AMRN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 28, 2026
Corporate Catalyst
Bullish
Impact 85
Amarin Says REDUCE-IT Post Hoc Analysis Showed About 30% Relative Risk Reduction In Major Adverse Cardiovascular Events Among Patients On Icosapent Ethyl At Least 1.5 Years; Hazard Ratio Of 0.73 Persisted After Discontinuation
This news is a strong positive catalyst for Amarin, as it provides further evidence of Vascepa's long-term benefits in reducing major adverse cardiovascular events. The persistence…
Jul 29, 2026
Corporate Catalyst
Bearish
Impact 92
Amarin Corp Q2 Sales $42.211M Miss $44.550M Estimate
Amarin Corp's Q2 sales of $42.211 million fell short of analyst expectations by 5.25% and, more critically, represent a 41.97% decline compared to the same period last year. This s…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.